Velocity Clinical Research, the leading multi-specialty clinical research organization, has partnered with Verified Clinical Trials (VCT) to set a new benchmark for patient safety and data quality in clinical trials through a new technological implementation at Velocity’s 80+ global sites. The collaboration addresses a … Read more
In a recent global trial, Velocity sites enrolled participants 50% faster than the average trial site. Additionally, Velocity supported the trial with over 30 research sites across several countries. In another recent trial, Velocity’s 20 sites outpaced average trial site enrollment rate by nearly … Read more
We’re proud to announce that Velocity is a founding member of the newly launched Association of MultiSite Research Corporations (AMRC)! This innovative trade association unites 14 leading organizations to address the systemic challenges in clinical trials and drive meaningful change across the industry. With … Read more
Congratulations to Paul Evans for being named one of the Top 50 Healthcare Technology CEOs of 2024! With Paul’s leadership, Velocity continues to redefine how clinical trials are conducted — leveraging VISION technology, centralization, and global site integration to accelerate drug development. His recognition … Read more
Velocity’s team contributed to the new Association of Clinical Research Professionals (ACRP) comprehensive whitepaper, titled ‘Responsible Oversight of Artificial Intelligence for Clinical Research Professionals.’ The development of our VISION technology has coincided with the proliferation of AI and large language models (LLMs). For recruitment … Read more
Robert Cupelo, MD, Principal Investigator in Syracuse, NY, shares his firsthand insights into the evolving landscape of Alzheimer’s treatment. Nearly two years after the FDA’s approval of lecanemab (Leqembi), and with the subsequent approval of donanemab (Kisunla), researchers are making crucial steps forward in … Read more
A new Fierce Biotech article features insights from Paul Evans on what to expect for clinical research in 2025. Topics include rising costs and uncertain regulations, as well as the continued emergence of site networks, AI-driven efficiency (with technology built “by trial sites, for … Read more
Rising costs, evolving regulations, and the unstoppable growth of AI are set to shape clinical trials in 2025. How will sites, new tech, promising obesity drugs, and shifting policies affect our industry? Read this article from Paul Evans featured on PharmiWeb: https://www.pharmiweb.com/article/2025-clinical-trials-outlook-six-industry-trends-to-expect
Congratulations to Henrik Watz, MD, on his exceptional presentation at the 2024 European Respiratory Society (ERS) ADVENT COPD Symposia! Dr. Watz, Medical Director and Principal Investigator at Velocity Clinical Research in Ahrensburg, Germany, joined Drs. Mona Bafadhel and Alberto Papi for a dynamic discussion, … Read more
Velocity Clinical Research, the leading fully integrated clinical site organization, announces the appointment of Renata Berardocco as Executive Vice President and Managing Director for the Latin America (LATAM) region. Renata has nearly two decades of experience in senior leadership roles and joins from Fortrea, … Read more
For decades, research into respiratory health has centered on conditions such as asthma and chronic obstructive pulmonary disease (COPD), predominantly because of their high prevalence. However, the incidence of respiratory diseases is increasing globally, with lesser-researched but equally debilitating conditions such as interstitial lung … Read more
Another outstanding achievement for Henrik Watz, MD, PhD, and our team in Ahrensburg, Germany! They led enrollment for a global chronic obstructive pulmonary disease (COPD) trial, more than doubling the enrollment of the next highest-performing site. Congratulations to Dr. Watz and our Ahrensburg team! … Read more
Learn more about Velocity's capabilities
Whether you’re ready to conduct a single-site study or a complex, high-volume trial, Velocity will ensure you have the right investigators, clinical staff, and patients for your research program.
Join a remarkable team doing remarkable work
Velocity careers offer competitive pay and benefits, and reward high performance with excellent opportunities.
Whether you're an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Velocity.